ISFR:LSE:LSE-iShares MSCI France UCITS (GBX)

ETF | Others |

Last Closing

USD 4662.25

Change

-57.00 (-1.21)%

Market Cap

USD 0.13B

Volume

4.72K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-1.25 (-0.66%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.19 (-1.01%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 547.46B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.01 (+0.04%)

USD 547.46B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.25 (+0.35%)

USD 266.08B
0QZO:LSE 0QZO

-1.55 (-1.64%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.56 (-0.91%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.04 (-0.12%)

USD 200.01B
0R24:LSE Intel Corp.

-0.80 (-3.74%)

USD 196.14B

ETFs Containing ISFR:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.93% 23% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.93% 21% F 33% F
Trailing 12 Months  
Capital Gain 4.28% 28% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.28% 26% F 38% F
Trailing 5 Years  
Capital Gain 40.17% 62% D 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.17% 60% D- 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.74% 72% C 74% C
Dividend Return 11.74% 72% C 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.07% 53% F 69% C-
Risk Adjusted Return 89.78% 90% A- 94% A
Market Capitalization 0.13B 53% F 30% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike